Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-08-30
2011-08-30
Gussow, Anne M. (Department: 1643)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S001110, C424S001650
Reexamination Certificate
active
08008256
ABSTRACT:
The invention relates to compositions and methods for treating diseases. In particular aspects, the invention relates to administering a combination of a disintegrin with a microtubule stabilizing agent useful for treatment of cancer.
REFERENCES:
patent: 4610879 (1986-09-01), Markland et al.
patent: 5066592 (1991-11-01), Huang et al.
patent: 5227400 (1993-07-01), Holton et al.
patent: 5248796 (1993-09-01), Chen et al.
patent: 5250683 (1993-10-01), Holton et al.
patent: 5254580 (1993-10-01), Chen et al.
patent: 5272171 (1993-12-01), Ueda et al.
patent: 5278324 (1994-01-01), Kingston et al.
patent: 5658785 (1997-08-01), Johnson
patent: 5814609 (1998-09-01), Markland et al.
patent: 6040174 (2000-03-01), Imler et al.
patent: 6147055 (2000-11-01), Hobart et al.
patent: 6294374 (2001-09-01), Sinha et al.
patent: 6365749 (2002-04-01), Kim et al.
patent: 6380394 (2002-04-01), Nicolaou et al.
patent: 6380395 (2002-04-01), Vite et al.
patent: 6387927 (2002-05-01), Altmann et al.
patent: 6399638 (2002-06-01), Vite et al.
patent: 6440944 (2002-08-01), Bruder et al.
patent: 6441186 (2002-08-01), Nicolaou et al.
patent: 6489314 (2002-12-01), Ashley et al.
patent: 6498257 (2002-12-01), Vite et al.
patent: 6518421 (2003-02-01), Li et al.
patent: 6531497 (2003-03-01), Nicolaou et al.
patent: 6537988 (2003-03-01), Lee
patent: 6583290 (2003-06-01), Julien et al.
patent: 6589968 (2003-07-01), Arslanian et al.
patent: 6593115 (2003-07-01), Vite et al.
patent: 6596875 (2003-07-01), White et al.
patent: 6605599 (2003-08-01), Vite et al.
patent: 6605726 (2003-08-01), Mulzer et al.
patent: 6610736 (2003-08-01), Klar et al.
patent: 6624310 (2003-09-01), Hoefle et al.
patent: 6638742 (2003-10-01), Hoffman
patent: 6660758 (2003-12-01), Nicolaou et al.
patent: 6670384 (2003-12-01), Bandyopadhyay et al.
patent: 6686380 (2004-02-01), Lee
patent: 6689802 (2004-02-01), DiMarco et al.
patent: 6710030 (2004-03-01), Markland et al.
patent: 6719540 (2004-04-01), Regueiro-Ren et al.
patent: 6727276 (2004-04-01), Lee
patent: 6730803 (2004-05-01), Iwasaki et al.
patent: 6780620 (2004-08-01), Li et al.
patent: 6800653 (2004-10-01), Regueiro-Ren et al.
patent: 6831090 (2004-12-01), Vite et al.
patent: 6858411 (2005-02-01), Julien et al.
patent: 6867333 (2005-03-01), Wessjohann et al.
patent: 6878699 (2005-04-01), Hemscheidt et al.
patent: 6893859 (2005-05-01), Ashley et al.
patent: 6900331 (2005-05-01), Taylor et al.
patent: 6906188 (2005-06-01), White et al.
patent: 6921650 (2005-07-01), Julien et al.
patent: 6930102 (2005-08-01), Klar et al.
patent: 6930187 (2005-08-01), Favreau et al.
patent: 6958401 (2005-10-01), White et al.
patent: 6982276 (2006-01-01), DiMarco et al.
patent: 6982280 (2006-01-01), Hoefle et al.
patent: 6998256 (2006-02-01), Arslanian
patent: 7008936 (2006-03-01), Voi et al.
patent: 7220724 (2007-05-01), Markland et al.
patent: 2002/0042109 (2002-04-01), Vite et al.
patent: 2002/0045609 (2002-04-01), Ashley et al.
patent: 2002/0062030 (2002-05-01), White et al.
patent: 2002/0094991 (2002-07-01), Gallaher
patent: 2002/0143038 (2002-10-01), Bandyopadhyay et al.
patent: 2002/0156110 (2002-10-01), Arslanian et al.
patent: 2002/0165257 (2002-11-01), Lee
patent: 2002/0165258 (2002-11-01), Lee
patent: 2002/0169190 (2002-11-01), Bandyopadhyay et al.
patent: 2002/0188014 (2002-12-01), DiMarco et al.
patent: 2002/0193361 (2002-12-01), Ashley et al.
patent: 2003/0004338 (2003-01-01), Li et al.
patent: 2003/0023082 (2003-01-01), Ashley et al.
patent: 2003/0045711 (2003-03-01), Ashley et al.
patent: 2003/0060623 (2003-03-01), Vite et al.
patent: 2003/0073677 (2003-04-01), Lee
patent: 2003/0087888 (2003-05-01), Regueiro-Ren et al.
patent: 2003/0144523 (2003-07-01), Klar et al.
patent: 2003/0144533 (2003-07-01), Iwasaki et al.
patent: 2003/0149281 (2003-08-01), Westermann et al.
patent: 2003/0176473 (2003-09-01), Taylor et al.
patent: 2003/0176710 (2003-09-01), Klar et al.
patent: 2003/0186884 (2003-10-01), Markland et al.
patent: 2003/0186965 (2003-10-01), Vite et al.
patent: 2003/0187039 (2003-10-01), Favreau et al.
patent: 2003/0187273 (2003-10-01), White et al.
patent: 2003/0191089 (2003-10-01), Regueiro-Ren et al.
patent: 2003/0203938 (2003-10-01), Nicolaou et al.
patent: 2003/0219877 (2003-11-01), Tang et al.
patent: 2003/0220295 (2003-11-01), Vite et al.
patent: 2003/0220503 (2003-11-01), Mulzer et al.
patent: 2004/0014978 (2004-01-01), Klar et al.
patent: 2004/0022869 (2004-02-01), Chen et al.
patent: 2004/0023345 (2004-02-01), Vite et al.
patent: 2004/0024032 (2004-02-01), Voi et al.
patent: 2004/0030147 (2004-02-01), White et al.
patent: 2004/0038324 (2004-02-01), Atadja et al.
patent: 2004/0039026 (2004-02-01), Nicoloou et al.
patent: 2004/0049051 (2004-03-01), Hoefle et al.
patent: 2004/0052785 (2004-03-01), Goodman et al.
patent: 2004/0053978 (2004-03-01), Lee et al.
patent: 2004/0058969 (2004-03-01), Buchmann et al.
patent: 2004/0072870 (2004-04-01), Nicolaou et al.
patent: 2004/0072882 (2004-04-01), Johnson et al.
patent: 2004/0082651 (2004-04-01), Wessjohann et al.
patent: 2004/0092478 (2004-05-01), Rothermel et al.
patent: 2004/0127432 (2004-07-01), Nicolaou et al.
patent: 2004/0132146 (2004-07-01), Benigni et al.
patent: 2004/0132754 (2004-07-01), Brandt et al.
patent: 2004/0157897 (2004-08-01), DiMarco et al.
patent: 2004/0176429 (2004-09-01), Li et al.
patent: 2004/0214871 (2004-10-01), Lee
patent: 2004/0253697 (2004-12-01), Julien et al.
patent: 2004/0259922 (2004-12-01), Hoefle et al.
patent: 2005/0038086 (2005-02-01), Ashley et al.
patent: 2005/0042275 (2005-02-01), Sonntag et al.
patent: 2005/0113429 (2005-05-01), Klar et al.
patent: 2005/0148657 (2005-07-01), Zygmunt et al.
patent: 2005/0159461 (2005-07-01), Lee
patent: 2005/0187270 (2005-08-01), Klar et al.
patent: 2005/0192440 (2005-09-01), White et al.
patent: 2005/0267306 (2005-12-01), Westermann et al.
patent: 2005/0282873 (2005-12-01), Rothermel
patent: 2006/0013836 (2006-01-01), Bandyopadhyay et al.
patent: 2006/0014796 (2006-01-01), Denni-Dischert et al.
patent: 2006/0040990 (2006-02-01), Klar et al.
patent: 2006/0046997 (2006-03-01), Klar et al.
patent: 2006/0063815 (2006-03-01), DiMarco et al.
patent: 2006/0246541 (2006-11-01), Minea et al.
patent: 2007/0123458 (2007-05-01), Markland et al.
patent: WO-00/18421 (2000-04-01), None
Skolnick and Fetrow. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotechnology, 2000. vol. 18, pp. 34-39.
Burgess, Shaheen, Ravera, Jaye, Donohue, and Winkles. Possible dissociation of the heparin binding and mitogenic activities of heparin binding (acidic fibroblast) growth factor 1 from its receptor binding activities by site directed mutagenesis of a single lysine residue. Journal of Cell Biology, 1990. vol. 111, pp. 2129-2138.
Lazar, Watanabe, Dalton and Sporn. Transforming growth factor alpha: mutation of aspartic acid 47 and leucine 48 results in different biological activities. Molecular and Cellular Biology, 1988. vol. 8, pp. 1247-1252.
Kim, Landen, Lin, Mangala, Lu, Nick, Stone, Merritt, Armaiz-Pena, Jennings, Coleman, Tice, and Sood. Combined anti-angiogenic therapy against VEGF and integrin alpha v beta 3 in an orthotopic model of ovarian cancer. Cancer Biology and Therapy, 2009. vol. 8, pp. 2261-2270.
Ahmed, Mills, Ibrahim, Temple, Blenkiron, Vias, Massie, Iyer, MC Geoch, Crawford, Nicke, Downward, Swanton, Bell, Earl, Laskey, Caldas, and Brenton. The extracellular matrix protein TGFB1 induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell, 2007. vol. 12, pp. 514-527.
Mattern et al., “Giloma cell integrin expression and their interactions with integrin antagonists”, Cancer Therapy, vol. 3, pp. 325-340, 2005.
European Search Report dated Dec. 30, 2009 for EP Application No. 06849695.9.
International Search Report dated Jun. 2, 2008 for PCT Application No. PCT/US06/04413.
Interview Summary dated Aug. 11, 2009 for U.S. Appl. No. 11/351,311.
McLane et al., Proceedings of the Society for Experimental Biology and Medicine, Proc. Soc. Exp. Biol. Med., 219(2):109-119 (1
Markland, Jr. Francis S
Pinski Jacek
Swenson Steven
Foley & Lardner LLP
Gussow Anne M.
University of Southern California
LandOfFree
Combination therapy for treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy for treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2702796